Lymphoproliferative Disorders
"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Descriptor ID |
D008232
|
| MeSH Number(s) |
C15.604.515 C20.683.515
|
| Concept/Terms |
Lymphoproliferative Disorders- Lymphoproliferative Disorders
- Disorder, Lymphoproliferative
- Disorders, Lymphoproliferative
- Lymphoproliferative Disorder
X-Linked Lymphoproliferative Disorder- X-Linked Lymphoproliferative Disorder
- Disorder, X-Linked Lymphoproliferative
- Disorders, X-Linked Lymphoproliferative
- Lymphoproliferative Disorder, X-Linked
- Lymphoproliferative Disorders, X-Linked
- X Linked Lymphoproliferative Disorder
- X-Linked Lymphoproliferative Disorders
- Epstein-Barr Virus Infection, Familial Fatal
- Epstein Barr Virus Infection, Familial Fatal
- Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males
- Epstein Barr Virus Induced Lymphoproliferative Disease In Males
- Familial Fatal Epstein-Barr Infection
- Familial Fatal Epstein Barr Infection
- Immunodeficiency 5
- Immunodeficiency 5s
- Duncan's Syndrome
- Lymphoproliferative Disease, X-Linked
- Disease, X-Linked Lymphoproliferative
- Diseases, X-Linked Lymphoproliferative
- Lymphoproliferative Disease, X Linked
- Lymphoproliferative Diseases, X-Linked
- X-Linked Lymphoproliferative Diseases
- Lymphoproliferative Syndrome, X-Linked, 1
- Purtilo Syndrome
- Purtilo Syndromes
- Syndrome, Purtilo
- Syndromes, Purtilo
- X-Linked Lymphoproliferative Disease
- X Linked Lymphoproliferative Disease
- X-Linked Lymphoproliferative Syndrome
- Lymphoproliferative Syndrome, X-Linked
- Lymphoproliferative Syndromes, X-Linked
- Syndrome, X-Linked Lymphoproliferative
- Syndromes, X-Linked Lymphoproliferative
- X Linked Lymphoproliferative Syndrome
- X-Linked Lymphoproliferative Syndromes
- Duncan Disease
- Disease, Duncan
- Immunodeficiency, X-Linked Progressive Combined Variable
- Immunodeficiency, X Linked Progressive Combined Variable
|
Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".
Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".
This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 17 | 5 | 22 |
| 2018 | 15 | 1 | 16 |
| 2019 | 4 | 2 | 6 |
| 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.
-
The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development. Front Immunol. 2021; 12:677027.
-
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination. Leuk Lymphoma. 2021 10; 62(10):2554-2555.
-
Immunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era. Exp Oncol. 2021 03; 43(1):87-91.
-
The management of chronic lymphoproliferative disorders at the time of SARS-Covid2 pandemic: weathering the storm. Leuk Lymphoma. 2020 12; 61(13):3278-3279.
-
Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease. Ann Hematol. 2020 08; 99(8):1945-1946.
-
COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant. 2020 11; 55(11):2180-2184.
-
Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients. Transplantation. 2019 11; 103(11):e369-e374.
-
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies. Front Immunol. 2019; 10:1757.
-
Rheumatoid Factors in Hepatitis B and C Infections: Connecting Viruses, Autoimmunity, and Cancer. Isr Med Assoc J. 2019 Jul; 21(7):480-486.
-
The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid Malignancies. Int J Mol Sci. 2019 Apr 09; 20(7).